Risk and Benefit Informed MTM Pharmacist Intervention in Heart Failure
Sponsor: Geisinger Clinic
Terminated
insufficient participants enrolled and study team has left Geisinger
Other terminated trials from Geisinger Clinic
Other Heart Failure trials with similar outcome
This NA trial investigates Heart Failure and is currently terminated or withdrawn. Geisinger Clinic leads this study, which shows 10 recorded versions since 2019 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
10 versions recorded-
Apr 2025 — Present [monthly]
Terminated NA
Status: Suspended → Terminated
-
Sep 2024 — Apr 2025 [monthly]
Suspended NA
-
Jul 2024 — Sep 2024 [monthly]
Suspended NA
-
Oct 2023 — Jul 2024 [monthly]
Suspended NA
Status: Enrolling By Invitation → Suspended
-
Sep 2022 — Oct 2023 [monthly]
Enrolling By Invitation NA
▶ Show 5 earlier versions
-
Sep 2021 — Sep 2022 [monthly]
Enrolling By Invitation NA
-
Jan 2021 — Sep 2021 [monthly]
Enrolling By Invitation NA
-
Aug 2020 — Jan 2021 [monthly]
Enrolling By Invitation NA
-
May 2019 — Aug 2020 [monthly]
Enrolling By Invitation NA
Status: Not Yet Recruiting → Enrolling By Invitation
-
Feb 2019 — May 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Geisinger Clinic
For direct contact, visit the study record on ClinicalTrials.gov .